EBGLYSS 250 MG/2 ML PEN

$1795.8100per ML

Strength

250 mg/2mL

Manufacturer

NDC

00002777211

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/1/2026

Active Ingredients

Approval Type

Biologic (BLA)

FDA Application

On Market Since

9/13/2024

Pharmacological Classes

Interleukin-13 Antagonist

Interleukin-13 Antagonists

0.0%

N/A

All

+5.0%

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Same classification

No related drugs found.